PMID: 7581261Aug 1, 1995Paper

Metformin attenuates agonist-stimulated calcium transients in vascular smooth muscle cells

Clinical and Experimental Hypertension : CHE
R V Sharma, R C Bhalla

Abstract

Metformin, an antidiabetic agent that increases insulin sensitivity, has been shown to lower blood pressure. However, the mechanism of action of metformin in vascular smooth muscle (VSM) cell is not fully understood. We have tested the hypothesis that metformin produces vascular changes by direct interaction with VSM cells by investigating its effect on platelet-derived growth factor (PDGF)- and angiotensin II (ANG II)-stimulated intracellular calcium concentration ([Ca2+]i) and VSM cell proliferation in response to PDGF in cultured cells. VSM cells were cultured from rat thoracic aorta and [Ca2+]i was estimated in single cells by image analysis. Treatment of VSM cells with 1 or 2 microgram/ml metformin significantly decreased (p < 0.05) PDGF- or ANG II-stimulated [Ca2+]i. Treatment of VSM cells with 1, 2, 5, or 10 micrograms/ml metformin had no significant effect on PDGF-stimulated [3H]-thymidine incorporation. However, metformin at pharmacological doses of 20 and 50 micrograms/ml significantly reduced (p < 0.05) PDGF-stimulated thymidine incorporation. We conclude that metformin mediates its vascular effects by attenuating agonist-stimulated [Ca2+]i.

References

Oct 1, 1992·The Journal of Clinical Investigation·V SarabiaA Klip
Jan 1, 1992·Diabetic Medicine : a Journal of the British Diabetic Association·R G Petty, J D Pearson
Apr 1, 1992·Journal of Clinical Pharmacy and Therapeutics·K Landin-Wilhelmsen
Jan 1, 1992·Clinical and Experimental Hypertension. Part A, Theory and Practice·G K Wambach, D Liu
Jan 1, 1991·Intensive Care Medicine·J H SchaeferA Distler
Sep 1, 1991·Journal of Medical Ethics·A E JamesR M Zaner
Aug 6, 1987·The New England Journal of Medicine·E FerranniniS Bevilacqua
Dec 1, 1981·British Journal of Clinical Pharmacology·G T Tucker
Nov 1, 1993·General Pharmacology·C J Bailey
Oct 15, 1993·Biochemical and Biophysical Research Communications·A HamannS Matthaei
Jan 1, 1993·The American Journal of Physiology·R V Sharma, R C Bhalla
Jan 1, 1993·Metabolism: Clinical and Experimental·S YoshiokaH Horikoshi
Jun 1, 1993·Hypertension·H A PershadsinghT W Kurtz

❮ Previous
Next ❯

Citations

Sep 1, 1996·Metabolism: Clinical and Experimental·S VermaJ H McNeill
Oct 10, 1997·Metabolism: Clinical and Experimental·J D PeulerJ R Sowers
Jul 27, 2001·Diabetes Technology & Therapeutics·N F Wiernsperger
Jan 5, 2002·Journal of Basic and Clinical Physiology and Pharmacology·S OzyazganA G Akkan
Sep 23, 2003·Diabetes & Metabolism·J C MamputuG Renier
Dec 3, 1999·Metabolism: Clinical and Experimental·J P OfensteinA P Sarnaik
Nov 28, 2013·The Journal of Pharmacology and Experimental Therapeutics·Luminita H PojogaRaouf A Khalil
Dec 3, 2016·Journal of Hypertension·Costas ThomopoulosThomas Makris
May 28, 2020·Frontiers in Pharmacology·Mingying DengAizong Shen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.